Scientists are excitedly investigating retatrutide, a promising treatment from Eli Lilly, as a potential step in weight loss . Unlike many previous approaches, retatrutide is a dual -action compound targeting both GLP-1 and GIP, substances that influence appetite and blood sugar regulation . Ear